Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma.

Strizova Z, Taborska P, Stakheev D, Partlová S, Havlova K, Vesely S, Bartunkova J, Smrz D.

Urol Oncol. 2019 Jul;37(7):503-509. doi: 10.1016/j.urolonc.2019.03.014. Epub 2019 Apr 26.

PMID:
31030972
2.

Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1.

Hladíková K, Partlová S, Koucký V, Bouček J, Fonteneau JF, Zábrodský M, Tachezy R, Grega M, Špíšek R, Fialová A.

Oral Oncol. 2018 Jul;82:75-82. doi: 10.1016/j.oraloncology.2018.05.010. Epub 2018 May 26.

PMID:
29909905
3.

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov D, Sepulveda MA, Gabrilovich DI.

Sci Immunol. 2016 Aug;1(2). pii: aaf8943. doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5.

4.

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines.

Kloudová K, Hromádková H, Partlová S, Brtnický T, Rob L, Bartůňková J, Hensler M, Halaška MJ, Špíšek R, Fialová A.

Oncotarget. 2016 Jul 19;7(29):46120-46126. doi: 10.18632/oncotarget.10028.

5.

[Immune System in Patients with Head and Neck Carcinoma].

Partlová S, Bouček J, Kloudová K, Zábrodský M, Špíšek R, Fialová A.

Klin Onkol. 2015;28 Suppl 4:4S86-94. Review. Czech.

PMID:
26647896
6.

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma.

Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, Fučíková J, Truxová I, Tachezy R, Špíšek R, Fialová A.

Oncoimmunology. 2015 Jan 30;4(1):e965570. eCollection 2015 Jan.

7.

Airway wall remodeling in young and adult rats with experimentally provoked bronchial asthma.

Uhlík J, Šimůnková P, Žaloudíková M, Partlová S, Jarkovský J, Vajner L.

Int Arch Allergy Immunol. 2014;164(4):289-300. doi: 10.1159/000366278. Epub 2014 Sep 16.

PMID:
25228052
8.

Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.

Truxova I, Pokorna K, Kloudova K, Partlova S, Spisek R, Fucikova J.

Immunol Lett. 2014 Jul;160(1):39-49. doi: 10.1016/j.imlet.2014.03.010. Epub 2014 Apr 12.

PMID:
24726860
9.

High hydrostatic pressure induces immunogenic cell death in human tumor cells.

Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron PF, Houska M, Rob L, Bartunkova J, Spisek R.

Int J Cancer. 2014 Sep 1;135(5):1165-77. doi: 10.1002/ijc.28766. Epub 2014 Feb 20.

10.

Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.

Fialová A, Partlová S, Sojka L, Hromádková H, Brtnický T, Fučíková J, Kocián P, Rob L, Bartůňková J, Spíšek R.

Int J Cancer. 2013 Mar 1;132(5):1070-9. doi: 10.1002/ijc.27759. Epub 2012 Aug 24.

Supplemental Content

Loading ...
Support Center